APA-ийн эшлэл(7 дахь хэвлэлт)

Keymeulen, B., Walter, M., Mathieu, C., Kaufman, L., Gorus, F., Hilbrands, R., . . . Pipeleers, D. (2010). Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

Чикаго-гийн эшлэл (17 дахь хэвлэлт)

Keymeulen, B., et al. Four-year Metabolic Outcome of a Randomised Controlled CD3-antibody Trial in Recent-onset Type 1 Diabetic Patients Depends on Their Age and Baseline Residual Beta Cell Mass. 2010.

MLA -ийн эшлэл (9 дэх хэвлэлт)

Keymeulen, B., et al. Four-year Metabolic Outcome of a Randomised Controlled CD3-antibody Trial in Recent-onset Type 1 Diabetic Patients Depends on Their Age and Baseline Residual Beta Cell Mass. 2010.